Log in to save to my catalogue

Impact of biomarker type on periprocedural myocardial infarction in patients undergoing elective PCI

Impact of biomarker type on periprocedural myocardial infarction in patients undergoing elective PCI

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2737466896

Impact of biomarker type on periprocedural myocardial infarction in patients undergoing elective PCI

About this item

Full title

Impact of biomarker type on periprocedural myocardial infarction in patients undergoing elective PCI

Publisher

Oxford: Oxford University Press

Journal title

European heart journal. Quality of care & clinical outcomes, 2023-11, Vol.9 (7), p.680-690

Language

English

Formats

Publication information

Publisher

Oxford: Oxford University Press

More information

Scope and Contents

Contents

Abstract
Background
Periprocedural myocardial infarction (MI) according to the Society for Cardiovascular Angiography and Interventions (SCAI) criteria has prognostic relevance among patients undergoing percutaneous coronary intervention (PCI). However, it is unclear whether the type of cardiac biomarker used for the diagnosis of periprocedur...

Alternative Titles

Full title

Impact of biomarker type on periprocedural myocardial infarction in patients undergoing elective PCI

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_2737466896

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2737466896

Other Identifiers

ISSN

2058-5225

E-ISSN

2058-1742

DOI

10.1093/ehjqcco/qcac075

How to access this item